Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.535 USD | +1.54% | +0.43% | -15.20% |
13/05 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
13/05 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
456M | - | - | - | |||
588B | ||||||
364B | ||||||
326B | ||||||
285B | ||||||
239B |